News
Carisma Therapeutics: First-of-its-kind engineered macrophage cell therapy platform shows ability to reduce tumor burden & activate anti-tumor immunity, improving overall survival in pre-clinical cancer models
- Details

Karl Naegler joins Wellington Partners as Managing Partner
- Details

Wellington Partners participates in $53 Million Series B financing at ImCheck
- Details
